Table 1.

Summary of studies on live attenuated vaccines

Reference	Study type (n of subjects)	Diagnosis pre-vaccine	Type of vaccine	Rec./de novo*	Comments
Measles
Kuzemko et al. [22]	Case report (2)	NS	Live attenuated	2/0	This was the first report on association between measles vaccine and NS
Kamei et al. [21]	Observational study (2)	NS	Live attenuated	0/0	Patients were receiving immunosuppression agents. Immunization resulted effective
Measles-Rubella
Kamei et al. [21]	Observational study (31)	NS	Live attenuated	0/0	Patients were receiving immunosuppression agents. Immunization resulted effective
Ajay et al. [23]	Observational study (76)	SSNS/FSGS	Live attenuated	NA	SSNS were in active treatment with steroids and FSGS with ciclosporin/tacrolimus
Measles-Mumps-Rubella
Ahuja and Wright [24]	Case report (1)	Healthy	Live attenuated	0/1	Steroid was effective in the treatment of NS, with no more relapse
Varicella-zoster
Alpay et al. [26]	Case series (20)	SSNS	Live attenuated	1/0	Relapse of NS in three weeks after vaccination
Furth et al. [27]	Prospective multicenter clinical trial (29)	SSNS	Live attenuated	0/0	All patients developed adequate VZV antibody levels
Kamei et al. [21]	Observational study (42)	NS	Live attenuated	2/0	Recurrences were reported at 16 and 22 day after vaccination

N/A not available, NS nephrotic syndrome, SDNS steroid-dependent nephrotic syndrome, SSNS steroid-sensitive nephrotic syndrome, VZV: Varicella-zoster virus